Materials & Methods > Core B > Apoptosis using TUNEL (TdT-mediated deoxyuridine-triphosphate nick end-labeling)
 

Turk Lab Standard Operating Procedure (SOP) for Immunohistochemical Staining for Myeloperoxidase

Materials
Literature

1. Cut paraffin sections @ 4 microns and place on positively-charged slides (Surgipath X-tra Slides® 00210)

2. Microwave slides briefly 1-2 min. on high power until paraffin is just melted or bake in 60 degree C oven for 1 hour.

3. Deparaffinize , run slides to water and perform steamer (Black and Decker HS2000 vegetable steamer) retrieval @ 90-100 C in Dako Target Retrieval solution (S1699) for 30 min. with 20 min. room temperature (RT) cooling time. Distilled water rinse several times.

4. Quench endogenous peroxidase with fresh 3% H202 for 5 min.

5. Rinse with distilled water several times and place in Tris with Tween buffer (Dako S3306)

6. Block tissue with A/B block (Vector) for 15 min. each with a Tris withTween buffer rinse between and after.

7. Wipe around tissue and block with protein block (Dako X0909 ) for 10 min.

8. Drip protein block off slide and apply primary antibody for overnight incubation. Primary antibody = rabbit polyclonal anti-human neutrophil myeloperoxidase (source: DakoCytomation A 0398), 1:800 dilution. The antibody can be used on formalin-fixed paraffin-embedded tissue using pig gram negative pneumonia as positive control.

9. Next day place slides in Tris with Tween buffer and rinse once.

10. Wipe around tissue and apply secondary antibody for 30 min. incubation at RT. (Dako, LSAB+ Kit, K0690;)

11. Tris with Tween buffer rinse.

12. Apply label (Streptavadin, Dako , LSAB+ Kit K0690) for 30 min. at RT

13. Rinse with distilled water several times.

14. Wipe around slides and apply diaminobenzidine (DAB Dako, K3466) for 5-10 min., monitor slides and place in water when desired intensity has been reached.

15. Rinse several times with distilled water.

16. Apply DAB enhancer (Dako, S1961) for 5 min. at RT.

17. Rinse several times with distilled water.

18. Give a 1 min. hematoxylin counterstain followed by 10 seconds in 1% acid alcohol and 1 min. in ammonia water to blue.

19. Run through graded alcohols to xylene and coverslip with permanent mounting media.

Material List (top)

1. Surgipath X-tra Slides® 00210

3. Black and Decker HS2000 vegetable steamer

3. Dako Target Retrieval solution (S1699)

5. Dako S3306

6. A/B block

8. Primary antibody, rabbit polyclonal anti-human neutrophil myeloperoxidase

10. Dako, LSAB+ Kit, K0690

12. Streptavadin, Dako , LSAB+ Kit K0690

14. DAB Dako, K3466

Literature (top)

Paraffin section immunophenotype of cutaneous and extracutaneous mast cell disease: comparison to other hematopoietic neoplasms.

Perivascular inflammation after balloon angioplasty of porcine coronary arteries.

Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis.

Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration.

Myeloperoxidase, a leukocyte-derived vascular NO oxidase.

Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases.

Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.

Prognostic value of myeloperoxidase in patients with chest pain.

Myeloperoxidase and plaque vulnerability.

Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species.

Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion.

Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

Myeloperoxidase and cardiovascular disease.

Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice.

Myeloperoxidase and its contributory role in inflammatory vascular disease.

Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase.

Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol.